CAS 713121-80-3

ML-193

CAS : 713121-80-3

Formule : C₂₈H₂₅N₅O₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 527.5942

Ref: IN-DA01E541

ML-193

CAS : 713121-80-3

ML-193

Degré de pureté : 98%

Masse moléculaire : 527.59g/mol

Ref: 54-OR1022908

ML-193

CAS : 713121-80-3

ML-193

Degré de pureté : ≥95%

Masse moléculaire : 527.59g/mol

Ref: 54-BUP11528

ML-193

CAS : 713121-80-3

ML-193: GPR55 antagonist, IC50 221nM, 27x selective over GPR35/CB1/CB2, may aid Parkinson's symptoms.

Formule : C₂₈H₂₅N₅O₄S

Degré de pureté : 97.74%

Couleur et forme : Solid

Masse moléculaire : 527.59

Ref: TM-T22103

ML-193

Produit contrôlé

CAS : 713121-80-3

Formule : C₂₈H₂₅N₅O₄S

Couleur et forme : Neat

Masse moléculaire : 527.594

Ref: TR-M425375

ML 193

CAS : 713121-80-3

ML 193 is a synthetic cannabinoid that binds to the CB2 receptor. It has been shown to reduce pain in animal models and may act by modifying nerve transmission in the spinal cord. ML 193 has also been shown to be a potent inhibitor of protein synthesis, which may contribute to its analgesic properties. The molecular modeling of ML 193 revealed that it is structurally similar to the endocannabinoid anandamide, which also inhibits protein synthesis. This similarity may account for its inhibition of protein synthesis and subsequent analgesic effects.

Formule : C₂₈H₂₅N₅O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 527.59 g/mol

Ref: 3D-NDB12180